#WorldPatientSafety Day 2020
Dr. Natalia Haraszkiewicz-Birkemeier
Scientific Policy Advisor | HTA Regulation I Knowledge Valorisation & IPR | EU Health & R&I Frameworks
‘No one should be harmed in healthcare’
Today we celebrate the #WorldPatientSafety Day. The pharmaceutical industry is one of the most innovative sectors in the world. Many novel therapies leverage technological advances and at the same time must meet the highest quality criteria to obtain marketing authorization and make medicines available for patients and HCPs. This means carefully selected suppliers, vendors and appropriate validated methodologies compliant with scientifically justified regulatory standards.
The highly capital-intensive R&D departments play a pivotal role to ensure safety, clinical benefits and efficacy of the medicine through its shelf life. The adequate monitoring and reporting of adverse events through the product (development) lifecycle from Phase I to the pivotal Phase III of clinical trials guarantee patients’ safety...
See also the link to the short slide show made on this occasion.
World Patient Safety Day 2019.